The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Abstract
Thromboxane (Tx) A 2 is a vasoconstrictor and platelet agonist. Aspirin affords cardioprotection through inhibition of TxA 2 formation by platelet cyclooxygenase (COX-1). Prostacyclin (PGI 2 ) is a vasodilator that inhibits platelet function. Here we show that injury-induced vascular proliferation and platelet activation are enhanced in mice that are genetically deficient in the PGI 2 receptor (IP) but are depressed in mice genetically deficient in the TxA 2 receptor (TP) or treated with a TP antagonist. The augmented response to vascular injury was abolished in mice deficient in both receptors. Thus, PGI 2 modulates platelet-vascular interactions in vivo and specifically limits the response to TxA 2 . This interplay may help explain the adverse cardiovascular effects associated with selective COX-2 inhibitors, which, unlike aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), inhibit PGI 2 but not TxA 2 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Self-citationPatrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Self-citationBunting, S., Moncada, S., Vane, J. R., & Gryglewski, R. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90125-8 · Cited by 950
Topper, J. N., Cai, J., Falb, D., & Gimbrone, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10417 · Cited by 843
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Schwartz, L., Bourassa, M. G., Lespérance, J., Aldridge, H. E., Kazim, F., Salvatori, V. A., Henderson, M., Bonan, R., & David, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182603 · Cited by 692
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 684
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Self-citationModulation of monocyte-endothelial cell interactions by platelet microparticles.
Barry, O. P., Praticò, D., Savani, R. C., & FitzGerald, G. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2592 · Cited by 544
Self-citationIncreased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
FitzGerald, G. A., Smith, B., Pedersen, A. K., & Brash, A. R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404263101701 · Cited by 497
Self-citationSynthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial Cells
Marcus, A. J., Weksler, B. B., Jaffe, E. A., & Broekman, M. J. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109967 · Cited by 380
Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists
FitzGerald, G. A. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90379-y · Cited by 353
Self-citationCoagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.
Thomas, D. W., Mannon, R. B., Mannon, P. J., Latour, A., Oliver, J. A., Hoffman, M., Smithies, O., Koller, B. H., & Coffman, T. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci5116 · Cited by 276
Self-citationNamba, T., Oida, H., Sugimoto, Y., Kakizuka, A., Negishi, M., Ichikawa, A., & Narumiya, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36979-x · Cited by 254
Serruys, P. W., Rutsch, W., Heyndrickx, G. R., Danchin, N., Mast, E. G., Wijns, W., Rensing, B. J., Vos, J., & Stibbe, J. (1991) · Circulation · doi:10.1161/01.cir.84.4.1568 · Cited by 236
Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2
Ueno, N., Murakami, M., Tanioka, T., Fujimori, K., Tanabe, T., Urade, Y., & Kudo, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100429200 · Cited by 195
Savage, M. P., Goldberg, S., Bové, A. A., Deutsch, E., Vetrovec, G. W., Macdonald, R. G., Bass, T. A., Margolis, J. R., Whitworth, H. B., Taussig, A. S., et al. (1995) · Circulation · doi:10.1161/01.cir.92.11.3194 · Cited by 124
Altered Vascular Injury Responses in Mice Deficient in Protease-Activated Receptor-1
Cheung, W.-M., D’Andrea, M. R., Andrade‐Gordon, P., & Damiano, B. P. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.3014 · Cited by 119
Walsh, M., Foley, J. F., & Kinsella, B. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907881199 · Cited by 105
Up-regulation of Endothelial Cyclooxygenase-2 and Prostanoid Synthesis by Platelets
Caughey, G. E., Cleland, L. G., Gamble, J. R., & James, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010606200 · Cited by 86
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
Nowak, J., & FitzGerald, G. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113895 · Cited by 76
Self-citationEndogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man.
Roy, L., Knapp, H. R., Robertson, R. M., & FitzGerald, G. A. (1985) · Circulation · doi:10.1161/01.cir.71.3.434 · Cited by 64
Self-citationRocca, B., Loeb, A. L., Strauss, J. F., Vezza, R., Habib, A., Li, H., & FitzGerald, G. A. (2000) · Nature Medicine · doi:10.1038/72334 · Cited by 59
Self-citationSuppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
Braden, G. A., Knapp, H. R., & FitzGerald, G. A. (1991) · Circulation · doi:10.1161/01.cir.84.2.679 · Cited by 55
Self-citation
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Self-citationPlatelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Autologous platelets as a source of proteins for healing and tissue regeneration
Anitua, E., Andia, I., Ardanza, B., Nurden, P., & Nurden, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-07-0440 · Cited by 1,495
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Self-citationArita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Metadata
- Authors
- Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A.
- Venue
- Science
- Published
- 2002-04-19
- Volume
- 296
- Issue
- 5567
- Pages
- 539-541
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2018716226
- Cited by
- 789
- References
- 27
- FWCI
- 39.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.